Mutual of America Capital Management LLC Has $1.19 Million Holdings in Solventum Co. (NYSE:SOLV)

Mutual of America Capital Management LLC trimmed its holdings in Solventum Co. (NYSE:SOLV) by 2.0% in the third quarter, Holdings Channel reports. The institutional investor owned 17,053 shares of the company’s stock after selling 352 shares during the period. Mutual of America Capital Management LLC’s holdings in Solventum were worth $1,189,000 at the end of the most recent reporting period.

Several other institutional investors have also made changes to their positions in SOLV. Tokio Marine Asset Management Co. Ltd. raised its holdings in Solventum by 4.2% in the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 4,966 shares of the company’s stock valued at $346,000 after acquiring an additional 200 shares in the last quarter. National Bank of Canada FI raised its position in Solventum by 4.0% during the second quarter. National Bank of Canada FI now owns 6,093 shares of the company’s stock valued at $314,000 after purchasing an additional 236 shares in the last quarter. IVC Wealth Advisors LLC raised its holdings in shares of Solventum by 5.0% during the 3rd quarter. IVC Wealth Advisors LLC now owns 6,649 shares of the company’s stock worth $464,000 after buying an additional 318 shares in the last quarter. Copeland Capital Management LLC bought a new position in shares of Solventum in the third quarter worth about $26,000. Finally, Mather Group LLC. bought a new position in Solventum in the 3rd quarter valued at approximately $27,000.

Wall Street Analysts Forecast Growth

SOLV has been the subject of several research analyst reports. The Goldman Sachs Group upped their price target on shares of Solventum from $48.00 to $54.00 and gave the stock a “sell” rating in a report on Monday, August 12th. Wells Fargo & Company lowered their target price on Solventum from $69.00 to $64.00 and set an “equal weight” rating for the company in a report on Friday, August 9th. Piper Sandler lifted their price target on Solventum from $71.00 to $75.00 and gave the company a “neutral” rating in a research note on Friday, November 8th. Wolfe Research initiated coverage on Solventum in a research note on Thursday, September 26th. They issued a “peer perform” rating for the company. Finally, BTIG Research started coverage on shares of Solventum in a research report on Thursday, September 5th. They set a “neutral” rating on the stock. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat, Solventum has an average rating of “Hold” and an average target price of $68.00.

Solventum Stock Up 1.1 %

Solventum stock opened at $71.58 on Tuesday. The stock’s 50 day moving average is $70.52 and its 200 day moving average is $62.35. Solventum Co. has a one year low of $47.16 and a one year high of $96.05. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.